Atlas Trials

Relapsed B-Cell Non-Hodgkin Lymphoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed B-Cell Non-Hodgkin Lymphoma

RecordFirmDate
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) (NCT04970901)ADC Therapeutics S.A.2022-06-17
Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma (NCT03994913)CARsgen Therapeutics Co., Ltd.2019-08-14
Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL (NCT02106091)Affimed GmbH2014-04-01

Track Relapsed B-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.